Both the US and the EU have regulatory standards governing the marketing of food supplements. Most of the US Food and Drug Administration (FDA)’s powers appear to be aimed at regulating what can be said about a substance rather than scutinising them before they are marketed. Claims may be either health claims related to a particular condition, or general structure/function claims.
In Europe, regulatory authority is divided between the EU and individual member states. The EU defines CBD as a novel food, requiring express authorisation.
In the US, its approval by the FDA in a pharmaceutical product precludes its use as a food or dietary supplement - though that has been subject to court involvement.
3 United States
5 Current status of CBD as a dietary supplement
6 Case study: melatonin - a comparison of evidence
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.